{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:02:59Z","timestamp":1789668179943,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008895","name":"TETFund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Taibah University Medical Sciences"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jtumed.2023.10.006","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T09:04:42Z","timestamp":1699088682000},"page":"175-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Design, synthesis, and molecular docking studies of N-substituted sulfonamides as potential anticancer therapeutics"],"prefix":"10.1016","volume":"19","author":[{"given":"Ibrahim T.","family":"Babalola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garba","family":"Suleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jtumed.2023.10.006_bib1","article-title":"The synthesis of conjugated peptides containing triazole and quinolone-3-carboxamide moieties designed as anticancer agents","volume":"19","author":"Esfandiari Mazandaran","year":"2021","journal-title":"Iran J Biotechnol"},{"issue":"3","key":"10.1016\/j.jtumed.2023.10.006_bib2","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1016\/j.arabjc.2019.12.006","article-title":"Synthesis, characterization, anticancer activity, and molecular docking of some new sugar hydrazone and arylidene derivatives","volume":"13","author":"Alotabi","year":"2020","journal-title":"Arab J Chem"},{"issue":"3","key":"10.1016\/j.jtumed.2023.10.006_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5493\/wjem.v2.i3.45","article-title":"Natural compounds as anticancer agents: experimental evidence","volume":"2","author":"Wang","year":"2012","journal-title":"World J Exp Med"},{"key":"10.1016\/j.jtumed.2023.10.006_bib4","series-title":"Proceedings of the world congress on engineering and computer science","article-title":"Design, evaluation and synthesis of novel compounds 3, 5-diphenil-1, 2, 4-oxadiazoles with farnesoid X receptor","year":"2016"},{"key":"10.1016\/j.jtumed.2023.10.006_bib5","series-title":"Adverse effects of cancer chemotherapy: anything new to improve tolerance and reduce sequelae?","first-page":"245","author":"Nurgali","year":"2018"},{"issue":"6","key":"10.1016\/j.jtumed.2023.10.006_bib6","article-title":"Effective therapy against severe anxiety caused by cancer: a case report and review of the literature","volume":"12","author":"Sakamoto","year":"2020","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.jtumed.2023.10.006_bib7","first-page":"1218","article-title":"The most common side effects experienced by patients were receiving first cycle of chemotherapy","volume":"47","author":"Altun","year":"2018","journal-title":"Iran J Public Health"},{"issue":"2","key":"10.1016\/j.jtumed.2023.10.006_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3892\/ijo.2018.4661","article-title":"From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment","volume":"54","author":"Schirrmacher","year":"2019","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.jtumed.2023.10.006_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-020-00213-8","article-title":"Overcoming cancer therapeutic bottleneck by drug repurposing","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10.1016\/j.jtumed.2023.10.006_bib10","first-page":"147","article-title":"Hair and cancer chemotherapy: consequences and nursing care \u2013 a literature study","volume":"10","author":"Batchelor","year":"2001","journal-title":"Eur J Cancer Care"},{"key":"10.1016\/j.jtumed.2023.10.006_bib11","series-title":"Seminars in cutaneous medicine and surgery","article-title":"Chemotherapy-induced alopecia","year":"2009"},{"issue":"10","key":"10.1016\/j.jtumed.2023.10.006_bib12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1470-2045(04)01597-9","article-title":"Stress, depression, the immune system, and cancer","volume":"5","author":"Reiche","year":"2004","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.jtumed.2023.10.006_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.jtumed.2023.10.006_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of cancer drug resistance: a brief review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv Pharm Bull"},{"issue":"23","key":"10.1016\/j.jtumed.2023.10.006_bib15","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/CIRCULATIONAHA.112.100560","article-title":"Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues","volume":"126","author":"Khouri","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jtumed.2023.10.006_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acr.2022.03.007","article-title":"An overview of chemotoxicity and radiation toxicity in cancer therapy","volume":"155","author":"Yazbeck","year":"2022","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.jtumed.2023.10.006_bib17","article-title":"The eukaryotic cell cycle","volume":"vol. 2","author":"Cooper","year":"2000"},{"issue":"3","key":"10.1016\/j.jtumed.2023.10.006_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/scientificamerican0996-62","article-title":"How cancer arises","volume":"275","author":"Weinberg","year":"1996","journal-title":"Sci Am"},{"issue":"2","key":"10.1016\/j.jtumed.2023.10.006_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pbiomolbio.2011.06.006","article-title":"The role of the microenvironment in tumor growth and invasion","volume":"106","author":"Kim","year":"2011","journal-title":"Prog Biophys Mol Biol"},{"issue":"6","key":"10.1016\/j.jtumed.2023.10.006_bib20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1601-0825.2011.01788.x","article-title":"Oral complications in the treatment of cancer patients","volume":"17","author":"Mosel","year":"2011","journal-title":"Oral Dis"},{"key":"10.1016\/j.jtumed.2023.10.006_bib21","first-page":"139","article-title":"An overview of cancer treatment modalities","volume":"1","author":"Abbas","year":"2018","journal-title":"Neoplasm"},{"issue":"3","key":"10.1016\/j.jtumed.2023.10.006_bib22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/bjc.2017.198","article-title":"Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter study","volume":"117","author":"Zhang","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtumed.2023.10.006_bib23","series-title":"The first miracle drugs: how the sulfa drugs transformed medicine","author":"Lesch","year":"2007"},{"issue":"6","key":"10.1016\/j.jtumed.2023.10.006_bib24","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1039\/D1NJ03809E","article-title":"Discovery of new chiral sulfonamides bearing benzoxadiazole as HIF inhibitors for non-small cell lung cancer therapy: design, microwave-assisted synthesis, binding affinity, in\u00a0vitro antitumoral activities and in silico studies","volume":"46","author":"Kahraman","year":"2022","journal-title":"New J Chem"},{"issue":"1","key":"10.1016\/j.jtumed.2023.10.006_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/14756366.2021.2004592","article-title":"Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines","volume":"37","author":"Mussi","year":"2022","journal-title":"J\u00a0Enzym Inhib Med Chem"},{"key":"10.1016\/j.jtumed.2023.10.006_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114257","article-title":"Design, synthesis and biological evaluation of sulfonamides inhibitors of XPO1 displaying activity against multiple myeloma cells","volume":"235","author":"Qu","year":"2022","journal-title":"Eur J Med Chem"},{"issue":"2","key":"10.1016\/j.jtumed.2023.10.006_bib27","doi-asserted-by":"crossref","first-page":"a025171","DOI":"10.1101\/cshperspect.a025171","article-title":"The whys and wherefores of antibiotic resistance","volume":"7","author":"Strachan","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"10.1016\/j.jtumed.2023.10.006_bib28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/aps.2011.156","article-title":"A\u00a0novel sulfonamide agent, MPSP-001, exhibits potent activity against human cancer cells in\u00a0vitro through disruption of microtubule","volume":"33","author":"Liu","year":"2012","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"10.1016\/j.jtumed.2023.10.006_bib29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12551-021-00795-9","article-title":"Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions","volume":"13","author":"Ovung","year":"2021","journal-title":"Biophys Rev"},{"key":"10.1016\/j.jtumed.2023.10.006_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.134978","article-title":"Spectroscopic, structural, and intermolecular interactions of 4-(2-hydroxy-3-methoxybenzylideneamino)-N-(5-methylisoxazol-3-yl) benzenesulfonamide enol-imine and keto-amine isomers","volume":"1279","author":"Louis","year":"2023","journal-title":"J\u00a0Mol Struct"},{"key":"10.1016\/j.jtumed.2023.10.006_bib31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-94-007-7359-2_12","article-title":"Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases","volume":"75","author":"Tafreshi","year":"2014","journal-title":"Subcell Biochem"},{"issue":"12","key":"10.1016\/j.jtumed.2023.10.006_bib32","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.3390\/app11125702","article-title":"Recent updates on the synthesis of bioactive quinoxaline-containing sulfonamides","volume":"11","author":"Irfan","year":"2021","journal-title":"Appl Sci"},{"issue":"3","key":"10.1016\/j.jtumed.2023.10.006_bib33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/cbdd.12675","article-title":"Iminothiazoline-sulfonamide hybrids as jack bean urease inhibitors; synthesis, kinetic mechanism and computational molecular modeling","volume":"87","author":"Saeed","year":"2016","journal-title":"Chem Biol Drug Des"},{"issue":"11","key":"10.1016\/j.jtumed.2023.10.006_bib34","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/jctb.3796","article-title":"Dansyl, a fluorescent photoprotecting group for microarray applications","volume":"87","author":"Heise","year":"2012","journal-title":"J\u00a0Chem Technol Biotechnol"},{"key":"10.1016\/j.jtumed.2023.10.006_bib35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2018.10.018","article-title":"Naphthalene, a versatile platform in medicinal chemistry: sky-high perspective","volume":"161","author":"Makar","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jtumed.2023.10.006_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113837","article-title":"Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation","volume":"226","author":"Wan","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10.1016\/j.jtumed.2023.10.006_bib37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/med.10047","article-title":"Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents","volume":"23","author":"Supuran","year":"2003","journal-title":"Med Res Rev"},{"issue":"8","key":"10.1016\/j.jtumed.2023.10.006_bib38","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2174\/1570159X15666170102145257","article-title":"Advantages of structure-based drug design approaches in neurological disorders","volume":"15","author":"Aarthy","year":"2017","journal-title":"Curr Neuropharmacol"},{"issue":"6","key":"10.1016\/j.jtumed.2023.10.006_bib39","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.bmc.2019.01.043","article-title":"Synthesis and urease inhibitory potential of benzophenone sulfonamide hybrid in\u00a0vitro and in silico","volume":"27","author":"Begum","year":"2019","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"10.1016\/j.jtumed.2023.10.006_bib40","first-page":"26","article-title":"The synthesis of sulfur model compounds as candidate for carbonic anhydrase inhibitors and anticancer drugs","volume":"3","author":"Suleiman","year":"2021","journal-title":"Int J Adv Eng Manag"},{"key":"10.1016\/j.jtumed.2023.10.006_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134233","article-title":"Antihypotensive potency of p-synephrine: spectral analysis, molecular properties and molecular docking investigation","volume":"1273","author":"Owen","year":"2023","journal-title":"J\u00a0Mol Struct"},{"issue":"2","key":"10.1016\/j.jtumed.2023.10.006_bib42","article-title":"Spectroscopic, DFT study, and molecular docking investigation of N-(3-methylcyclohexyl)-2-phenylcyclopropane-1-carbohydrazide as a potential antimicrobial drug","volume":"100","author":"Idante","year":"2023","journal-title":"J\u00a0Indian Chem Soc"},{"issue":"1","key":"10.1016\/j.jtumed.2023.10.006_bib43","first-page":"32","article-title":"In silico analysis of noscapine compounds as anti-tumor agents targeting the tubulin receptor","volume":"18","author":"Nulamuga","year":"2023","journal-title":"J\u00a0Taibah Univ Med Sci"}],"container-title":["Journal of Taibah University Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658361223001555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658361223001555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:33:09Z","timestamp":1761647589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1658361223001555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1658361223001555"],"URL":"https:\/\/doi.org\/10.1016\/j.jtumed.2023.10.006","relation":{},"ISSN":["1658-3612"],"issn-type":[{"value":"1658-3612","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and molecular docking studies of N-substituted sulfonamides as potential anticancer therapeutics","name":"articletitle","label":"Article Title"},{"value":"Journal of Taibah University Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtumed.2023.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}